New York, May 24, 2026, 14:02 EDT
• Dentsply Sirona finished Friday at $10.21, a gain of 2.8% for the session and up around 1.4% versus last Friday.
• The U.S. markets are closed for the weekend, and Nasdaq will be closed Monday for Memorial Day.
• The next planned update from the company is at Stifel’s Jaws & Paws conference on Wednesday.
Dentsply Sirona Inc. shares picked up late in the week, handing investors a modest gain ahead of the U.S. holiday and an upcoming management presentation seen as a possible test for the dental-products company’s turnaround story.
Nasdaq-listed shares finished Friday at $10.21, gaining 2.8% in the session and up 1.4% from last Friday’s $10.07 close. The stock touched a low of $9.40 on Tuesday but bounced back later in the week.
What’s at issue now: The stock is trading close to its recent lows, and with Nasdaq shut Monday, May 25, for Memorial Day, there won’t be another session until Tuesday. Nasdaq’s standard hours are 9:30 a.m. to 4 p.m. Eastern Time.
Stocks ended higher again. The S&P 500 picked up 0.9% this week, while the Dow climbed 2.1% and the Nasdaq Composite gained 0.5%. U.S. stocks logged an eighth weekly gain in a row.
Dentsply has a light near-term schedule. The company is set to present at the 2026 Stifel Jaws & Paws Conference on May 27 at 3:35 p.m. EDT, then holds its annual stockholder meeting on June 2.
Dentsply Sirona holders are watching to see if the “Return-to-Growth” plan is gaining traction. Chief Executive Dan Scavilla said with the first-quarter numbers that Dentsply was “executing” on the plan, and the quarter showed the firm’s “current stage of transformation.” Dentsply Sirona
Dentsply’s first-quarter results sent a mixed signal. Net sales for the quarter came in at $880 million, holding steady versus the same time last year. The company posted a GAAP net loss of 5 cents a share, while adjusted EPS was 27 cents. Adjusted EPS strips out some costs and items.
Constant-currency sales dropped 6.7%, signaling pressure on volume and demand below the headline number. The company held its 2026 targets for net sales at $3.5 billion to $3.6 billion and adjusted EPS at $1.40 to $1.50.
Dentistry names like Henry Schein, Align Technology and Envista keep facing questions as investors watch for steadier patient flow and spending on pricier procedures. Leerink’s Michael Cherny told Reuters earlier this year the Street looked for “better/less bad results.” J.P. Morgan’s Lilia-Celine B. Lozada said the sector “generally remains soft.” Reuters
Dentsply is moving to expand its U.S. distribution. On May 4, the company announced Atlanta Dental Supply will start selling its connected technology solutions portfolio in the U.S. from Aug. 1. That lineup includes CEREC, intraoral scanning, and digital imaging gear. Mark Bezjak, group vice president for the Americas, said the distribution push is “a core element” of Dentsply’s commercial strategy. Dentsply Sirona
Dentsply got a pop on Friday, but that could just be a quick rebound. The company still faces slow constant-currency sales, slimmer gross margin and restructuring costs hitting timing. If dental demand keeps lagging or tariffs, pricing, and dealer inventory trends turn worse, management could have a tougher time holding to its full-year outlook.
Investors look to the week ahead for more than just broad promises. They want to hear about sales trends after the first quarter, how much progress distributor deals are making, and if cost cutting will defend margins without hurting growth. The stock moving back above $10 gives Dentsply a little space, but not a lot.
